Current approach to fertility preservation by embryo cryopreservation

Slides:



Advertisements
Similar presentations
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Advertisements

Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 
Male infertility: a biomarker of individual and familial cancer risk
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment  Javier Domingo, M.D., Vicente.
Age at menarche: a predictor of diminished ovarian function?
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience  Kutluk Oktay, M.D.,
Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?  Kutluk.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Hepatitis and reproduction
Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day.
Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Sanghoon Lee, M. D. , Elke Heytens, Ph. D. , Fred Moy, Ph. D
Medical treatment of ectopic pregnancy: a committee opinion
Live birth of twins derived from zona-free oocytes
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Oocyte cryopreservation
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis  Cui Hong Zheng, M.D., Ph.D.,
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer  Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),
Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation  Jacques Donnez,
A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients  Eric J. Forman, M.D.,
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Male infertility: a biomarker of individual and familial cancer risk
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.
An employer's experience with infertility coverage: a case study
Inequity between male and female coverage in state infertility laws
Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis  Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,
Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.
Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro.
Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study  Carlo.
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertility  Erkan Buyuk, M.D.,
Tania Luisa Stevenson, M.B.Ch.B., Hany Lashen, F.R.C.O.G. 
Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.
Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity  Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.
Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success  J. Ryan Martin, M.D., Jason G. Bromer,
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Fertility and Sterility
In vitro fertilization and breast cancer: is there cause for concern?
Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects  Kutluk Oktay, M.D., Ph.D., Giuliano Bedoschi,
Effectiveness of highly purified human menopausal gonadotropin vs
S. Samuel Kim, M.D.  Fertility and Sterility 
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Yohei Hayashi, Ph. D. , Mitinori Saitou, M. D. , Ph. D
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr.
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Multiple fertility preservation approach in cancer patients: IVF and embryo freezing using donor or husband sperm combined with oocyte cryopreservation.
Which patients pursue fertility preservation treatments
Fertility Preservation in Breast Cancer
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.
Presentation transcript:

Current approach to fertility preservation by embryo cryopreservation Giuliano Bedoschi, M.D., Kutluk Oktay, M.D.  Fertility and Sterility  Volume 99, Issue 6, Pages 1496-1502 (May 2013) DOI: 10.1016/j.fertnstert.2013.03.020 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 “Pyramid” of fertility preservation. Medical interventions including chemotherapy, radiotherapy, and surgery act as insults to ovarian reserve and may result in premature ovarian failure and infertility. However, of all the patients at risk for premature ovarian failure, only a fraction will be referred to fertility preservation consultation (FPC) (5). Of those even a smaller fraction will be undergoing fertility preservation due to social, economic, or technical hurdles. Of all techniques offered, embryo cryopreservation is most commonly used, followed by oocyte cryopreservation, ovarian tissue freezing, and other methods, in that order. Fertility and Sterility 2013 99, 1496-1502DOI: (10.1016/j.fertnstert.2013.03.020) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 2 A simplified scheme for fertility preservation options. In pre-pubertal girls, ovarian cryopreservation may be the only practical option. In post-pubertal females, a wider range of options is available with embryo cryopreservation being the most established method for patients with a male partner or who wish to use donor sperm. Oocyte cryopreservation, now considered an established method of fertility preservation by the American Society for Reproductive Medicine (7), is an option for older post-pubertal female children and single women. In cases where there is insufficient time for ovarian stimulation, ovarian cryopreservation as well as immature oocyte retrieval for in vitro maturation (followed by oocyte or embryo cryopreservation) may also be considered. In vitro growth (IVG) of isolated immature follicles is a theoretical option that may offer advantages in the future for females who have undergone ovarian freezing when there is a risk of ovarian involvement with cancer. The simplest approach to fertility preservation could have been a pharmacological intervention; however there is no proven hormonal treatment to preserve fertility. In the future, with the discovery of the mechanisms responsible for the chemotherapy-induced damage to the primordial follicles (8, 66), targeted pharmacological methods may be developed. Fertility and Sterility 2013 99, 1496-1502DOI: (10.1016/j.fertnstert.2013.03.020) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions